Birch Grove Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Birch Grove Capital’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62,000	Closed	-$378K	–	55
2021 Q3	$378K	Hold	62,000	–	–	0.18%	45
2021 Q2	$510K	Buy	+62,000	New	+$527K	0.25%	36

Birch Grove Capital's FLXN Position: Q4 2021 in Review

Birch Grove Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 62,000 shares — an estimated $378K sold.

Birch Grove Capital first reported a position in FLXN in Q2 2021 and held it in 2 quarters. The position peaked at $510K in Q2 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Birch Grove Capital reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Birch Grove Capital sold 62,000 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $378K.
Birch Grove Capital first reported a position in Flexion Therapeutics, Inc. in Q2 2021 and held it in 2 quarters.
Birch Grove Capital's Flexion Therapeutics, Inc. position peaked at $510K in Q2 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Birch Grove Capital's 13F filing for Q4 2021, filed 14 Feb 2022.